Novo Holdings co-led a series C round for orthodontic brace technology developer Swift Health Systems, which has now raised more than $70m.
US-based discreet orthodontic braces manufacturer Swift Health Systems raised $45m in a series C round yesterday co-led by pharmaceutical firm Novo Holdings.
Healthcare-focused investment firm Vivo Capital and life sciences-focused venture capital firm VenBio Partners co-led the round.
Founded in 2014, Swift Health has devised orthodontic braces branded Inbrace to help realign and straighten out teeth. Inbrace uses invisible wires that can be programmed through Swift’s software platform to fit the patient based on digital scans.
The series C cash…